✦ LIBER ✦

Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes

✍ Scribed by Manfrid Eltze; Volker Figala

Book ID: 115881457
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 592 KB
Volume: 158
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(88)90247-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Affinity profile of S(-)-hyoscyamine for

Affinity profile of S(-)-hyoscyamine for muscarinic receptor subtypes

✍ S. Scapecchi; C. Bellucci; C. Ghelardini; A. Gheri; A. Giotti; F. Gualtieri; A. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Development of Selective Antisera for Mu

Development of Selective Antisera for Muscarinic Cholinergic Receptor Subtypes

✍ BARRY B. WOLFE; ROBERT P. YASUDA 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB

Stereoselectivity at muscarinic receptor

Stereoselectivity at muscarinic receptor subtypes: observations with the enantiomers of phenglutarimide

✍ Günter Lambrecht; Roland Feifel; Ernst Mutschler 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 1 views

Muscarinic toxins with selectivity for m

Muscarinic toxins with selectivity for muscarinic receptor subtypes: Differential binding patterns in cloned and native receptors

✍ D Jerusalinsky; E. Kornisiuk; A. Harvey; P. Alfaro; M. Alonso; R. Durán; C. Cerv 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Stereoselectivity of the enantiomers of

Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypes

✍ Günter Lambrecht; Roland Feifel; Ulrich Moser; Arne J. Aasen; Magali Waelbroeck; 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 244 KB

The relative selectivity of anticholiner

The relative selectivity of anticholinergic drugs for the M1 and M2 muscarinic receptor subtypes

✍ Dr. Robert E. Burke 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 775 KB

Anticholinergic drugs are used to treat a number of neurologic disorders, inctuding parkinsonism, vestibular disturbances, and dystonia. Traditionally, these drugs have been thought to act in similar fashion, as competitive antagonists at a single class of muscarink receptors, and not to differ sign